These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 21354891)

  • 41. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
    Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
    Jarius S; Franciotta D; Paul F; Bergamaschi R; Rommer PS; Ruprecht K; Ringelstein M; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2012 Sep; 320(1-2):32-7. PubMed ID: 22705047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
    Park JS; Hwang SJ; Shin JH; Kim DS
    J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [European treatment recommendation of neuromyelitis optica spectrum disorders: critical remarks and case discussion].
    Kőszegi E; Illés Z
    Ideggyogy Sz; 2012 May; 65(5-6):201-6. PubMed ID: 22724289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
    Juryńczyk M; Craner M; Palace J
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
    Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
    Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
    Lai C; Tian G; Takahashi T; Liu W; Yang L; Zhang X
    J Neuroophthalmol; 2011 Mar; 31(1):16-9. PubMed ID: 21150455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
    Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
    Juryńczyk M; Weinshenker B; Akman-Demir G; Asgari N; Barnes D; Boggild M; Chaudhuri A; D'hooghe M; Evangelou N; Geraldes R; Illes Z; Jacob A; Kim HJ; Kleiter I; Levy M; Marignier R; McGuigan C; Murray K; Nakashima I; Pandit L; Paul F; Pittock S; Selmaj K; de Sèze J; Siva A; Tanasescu R; Vukusic S; Wingerchuk D; Wren D; Leite I; Palace J
    J Neurol; 2016 Jan; 263(1):140-9. PubMed ID: 26530512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
    Asgari N; Skejø HP; Lillevang ST; Stenager E
    Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
    Banati M; Csecsei P; Koszegi E; Nielsen HH; Suto G; Bors L; Trauninger A; Csepany T; Rozsa C; Jakab G; Molnar T; Berthele A; Kalluri SR; Berki T; Illes Z
    Eur J Neurol; 2013 Nov; 20(11):1492-5. PubMed ID: 23293933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.
    McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Hinson SR; Kryzer TJ; Lucchinetti CF; Weinshenker BG; Wingerchuk DM; Shuster EA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1134-8. PubMed ID: 19752303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
    Ambika S; Balasubramanian M; Theresa L; Veeraputhiran A; Arjundas D
    Int Ophthalmol; 2015 Dec; 35(6):801-6. PubMed ID: 25682013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
    Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
    Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
    Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
    Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.